Skip to main content

Table 4 Drug-related adverse events

From: Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial

Adverse events

RT

(n = 38)

RT + flumazenil

(n = 38)

Propofol

(n = 38)

Hypotension

   

 Anesthesia induction

3(7.9)

9(23.7)

4(10.5)

 Anesthesia maintenance

10(26.3)

12(31.6)

26(68.4)

 Anesthesia recovery

0(0.0)

0(0.0)

0(0.0)

 PACU

0(0.0)

0(0.0)

0(0.0)

Sinus bradycardia

   

 Anesthesia induction

0(0.0)

0(0.0)

0(0.0)

 Anesthesia maintenance

1(2.6)

1(2.6)

1(2.6)

 Anesthesia recovery

0(0.0)

0(0.0)

0(0.0)

 PACU

0(0.0)

0(0.0)

0(0.0)

Hypoxemia

   

 Anesthesia induction

0(0.0)

0(0.0)

0(0.0)

 Anesthesia maintenance

0(0.0)

0(0.0)

0(0.0)

 Anesthesia recovery

0(0.0)

0(0.0)

1(2.6)

 PACU

0(0.0)

0(0.0)

0(0.0)

Agitation and tremors

0(0.0)

0(0.0)

0(0.0)

Injection pain

0(0.0)

2(5.3)

7(18.4)

Movement during procedure

1(2.6)

1(2.6)

1(2.6)

Intraoperative awareness

0(0.0)

0(0.0)

0(0.0)

Postoperative nausea and vomiting

0(0.0)

0(0.0)

2(5.3)

Airway intervention after LMA extraction

1(2.6)

0(0.0)

1(2.6)

Complications at POD14

0(0.0)

0(0.0)

0(0.0)

  1. Data are presented as numbers (percentages)
  2. Abbreviations: LMA, laryngeal mask airway; PACU, postanesthesia care unit; POD14, 14 days after surgery; RT, remimazolam tosilate